The rapid microbiology testing market is booming, projected to reach $5.51 billion by 2025, with a 9.53% CAGR. Driven by infectious disease prevalence and technological advancements, this report analyzes market trends, key players (Abbott, BD, bioMérieux), and future growth prospects. Explore the latest insights on PCR, ELISA, and other rapid testing methods.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.